BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 36695823)

  • 21. Comparison of the role of 18 F-fluorodeoxyglucose PET/computed tomography and 68 Ga-labeled FAP inhibitor-04 PET/CT in patients with malignant mesothelioma.
    Güzel Y; Kömek H; Can C; Kaplan İ; Kepenek F; Ebinç S; Büyükdeniz MP; Gündoğan C; Oruç Z
    Nucl Med Commun; 2023 Jul; 44(7):631-639. PubMed ID: 37114422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-to-blood ratio for assessment of fibroblast activation protein receptor density in pancreatic cancer using [
    Chen R; Yang X; Yu X; Zhou X; Ng YL; Zhao H; Li L; Huang G; Zhou Y; Liu J
    Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):929-936. PubMed ID: 36334106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved cancer detection in Waldeyer's tonsillar ring by
    Serfling S; Zhi Y; Schirbel A; Lindner T; Meyer T; Gerhard-Hartmann E; Lapa C; Hagen R; Hackenberg S; Buck AK; Scherzad A
    Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1178-1187. PubMed ID: 33057927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of fibroblast activation protein expressing tumor volume calculated from [
    Zhao L; Pang Y; Chen S; Chen J; Li Y; Yu Y; Huang C; Sun L; Wu H; Chen H; Lin Q
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):593-601. PubMed ID: 36222855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual-tracer PET/CT protocol with [
    Wegen S; Weindler J; Voltin CA; van Heek L; Schomäcker K; Fischer T; Marnitz S; Kobe C; Drzezga A; Roth KS
    Strahlenther Onkol; 2024 Jan; 200(1):28-38. PubMed ID: 37584717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Head-to-Head Comparison of [
    Wegen S; van Heek L; Linde P; Claus K; Akuamoa-Boateng D; Baues C; Sharma SJ; Schomäcker K; Fischer T; Roth KS; Klußmann JP; Marnitz S; Drzezga A; Kobe C
    Mol Imaging Biol; 2022 Dec; 24(6):986-994. PubMed ID: 35771317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [
    Wei Y; Cheng K; Fu Z; Zheng J; Mu Z; Zhao C; Liu X; Wang S; Yu J; Yuan S
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1671-1681. PubMed ID: 34870727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Application of [
    Zhang H; An J; Wu P; Zhang C; Zhao Y; Tan D; Shi C; Ge X
    Contrast Media Mol Imaging; 2022; 2022():6596702. PubMed ID: 36051919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Evaluation of
    Zhao L; Wen X; Xu W; Pang Y; Sun L; Wu X; Xu P; Zhang J; Guo Z; Lin Q; Chen X; Chen H
    J Nucl Med; 2023 Aug; 64(8):1210-1217. PubMed ID: 37142301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of 68 Ga-FAPI-04 PET/CT on Staging and Therapeutic Management in Patients With Digestive System Tumors.
    Kosmala A; Serfling SE; Schlötelburg W; Lindner T; Michalski K; Schirbel A; Higuchi T; Hartrampf PE; Buck AK; Weich A; Werner RA
    Clin Nucl Med; 2023 Jan; 48(1):35-42. PubMed ID: 36354691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential utility of [
    Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of tumour grade and survival outcome using pre-treatment PET- and MRI-derived imaging features in patients with resectable pancreatic ductal adenocarcinoma.
    Dunet V; Halkic N; Sempoux C; Demartines N; Montemurro M; Prior JO; Schmidt S
    Eur Radiol; 2021 Feb; 31(2):992-1001. PubMed ID: 32851447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [
    Guberina N; Kessler L; Pöttgen C; Guberina M; Metzenmacher M; Herrmann K; Mucha M; Rischpler C; Indenkämpen F; Siveke JT; Treckmann J; Umutlu L; Kasper S; Fendler WP; Stuschke M
    Sci Rep; 2022 Sep; 12(1):16261. PubMed ID: 36171444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Head-to-head Intra-individual Comparison of [
    Novruzov E; Dendl K; Ndlovu H; Choyke PL; Dabir M; Beu M; Novruzov F; Mehdi E; Guliyev F; Koerber SA; Lawal I; Niegisch G; Debus J; Haberkorn U; Sathekge M; Giesel FL
    Mol Imaging Biol; 2022 Aug; 24(4):651-658. PubMed ID: 35349039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual targeting PET tracer [
    Wang R; Jakobsson V; Wang J; Zhao T; Peng X; Li B; Xue J; Liang N; Zhu Z; Chen X; Zhang J
    Theranostics; 2023; 13(9):2979-2992. PubMed ID: 37284441
    [No Abstract]   [Full Text] [Related]  

  • 36.
    Shangguan C; Yang C; Shi Z; Miao Y; Hai W; Shen Y; Qu Q; Li B; Mi J
    Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):285-294. PubMed ID: 37634891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of
    Yokose T; Kitago M; Matsusaka Y; Masugi Y; Shinoda M; Yagi H; Abe Y; Oshima G; Hori S; Endo Y; Toyama K; Iwabuchi Y; Takemura R; Ishii R; Nakahara T; Okuda S; Jinzaki M; Kitagawa Y
    Cancer Med; 2020 Jun; 9(12):4059-4068. PubMed ID: 32281301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Static and Dynamic
    Lang M; Spektor AM; Hielscher T; Hoppner J; Glatting FM; Bicu F; Hackert T; Heger U; Pausch T; Gutjahr E; Rathke H; Giesel FL; Kratochwil C; Tjaden C; Haberkorn U; Röhrich M
    J Nucl Med; 2023 Feb; 64(2):244-251. PubMed ID: 35906094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor Characterization by [
    Rasinski P; Af Burén S; Holstensson M; Nilsson T; Loizou L; Tran TA; Sparrelid E; Löhr JM; Axelsson R
    J Nucl Med; 2023 Aug; 64(8):1232-1237. PubMed ID: 37348917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical prospective study of Gallium 68 (
    Jinghua L; Kui X; Deliang G; Bo L; Qian Z; Haitao W; Yaqun J; Dongde W; Xigang X; Ping J; Shengli T; Zhiyong Y; Yueming H; Zhonglin Z; Yong H; Yufeng Y
    Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2152-2166. PubMed ID: 36809426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.